Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Harmony Biosciences Holdings, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2022 8-K Quarterly results
05/03/2022 8-K Investor presentation, Quarterly results
02/28/2022 8-K Quarterly results
11/09/2021 8-K Investor presentation, Quarterly results
08/10/2021 8-K Investor presentation
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Transcript of Conference Call held by the Company on August 10, 2021",
"Investor Presentation"
05/11/2021 8-K Quarterly results
03/25/2021 8-K Quarterly results
11/12/2020 8-K Investor presentation, Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : November 12, 2020 HARMONY BIOSCIENCES HOLDINGS, INC. Delaware 001-39450 82-2279923 630 W. Germantown Pike, Suite 215 Plymouth Meeting, PA 19462 539-9800 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant...",
"HARMONY BIOSCIENCES REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATES",
"Investor Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy